Benjamin Samelson-Jones

Assistant Professor of Pediatrics
Division of Hematology and the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States

Presentation(s):

• OC 02.4 - Long-Term Follow-Up of Participants in the Phase I/II Trial of Dirloctocogene Samoparvovec (SPK-8011): Durable FVIII Expression and Clinically Meaningful Reduction of Bleeding

  Saturday, June 22, 2024
  13:45 – 14:00 ICT